DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Matsuo T, Yamasaki O.
Vogt-Koyanagi-Harada disease-like posterior uveitis in the course of nivolumab (anti-PD1 antibody), interposed by vemurafenib (BRAF inhibitor), for metastatic cutaneous malignant melanoma.
Clin Case Rep 2017;
5: 694-700
doi:10.1002/ccr3.911
We do not assume any responsibility for the contents of the web pages of other providers.